CURRICULUM VITAE

Dudley A. Hudspeth, MD

**** * ****** ***** **

Tempe, AZ 85282

advvaj@r.postjobfree.com

480-***-****

EDUCATION:

UNDERGRADUATE

AB/ Biochemistry

**** **** ********** ******, NC

MEDICAL SCHOOL M.D.

1983 1987 University of North Carolina – Chapel Hill Chapel Hill, NC POSTGRADUATE

7/87 – 6/88 Georgetown University Washington, DC, Categorical General Surgery Internship 7/88 – 6/91 Bowman Gray School of Medicine Winston Salem, NC, General Surgery Residency 7/91 – 6/92 Chief Resident – General Surgery Residency 7/92 – 6/93 Research Fellow – Cardiothoracic Surgery 7/93 – 6/94 Clinical Fellow – Cardiothoracic Surgery 7/94 – 6/95 Chief Resident – Cardiothoracic Surgery BOARD CERTIFICATIONS:

American Board of Surgery, 1993, Recertified 2003

American Board of Thoracic Surgery 1996

Recertified 2005 and 2015

LICENSES: North Carolina, Arizona, Georgia, Pennsylvania NPI

DEA

PROFESSIONAL MEMBERSHIPS:

American College of Surgeons (Fellow)

Society of Thoracic Surgeons (Active Member) Society for Vascular Surgery (Fellow) WORK HISTORY:

Private Practice – Cardiothoracic and Vascular Surgery Phoenix Metropolitan Area, Arizona July 1995 to present – See Below Arizona CT Surgery LLC 2013 to Present

485 South Dobson Road, Chandler AZ 85224

Provider of Cardiovascular and Thoracic Surgery services to the greater Phoenix area Appointed Clinical Assistant Professor, Division of Clinical Education Arizona College of Osteopathic Medicine May 2016

Clinical position to enable teaching of Surgery Residents at IASIS Hospitals Named Director of Cardiovascular and Thoracic Surgery IASIS Hospitals in Arizona Sept 2015

Recipient of Inaugural Society of Thoracic Surgeons – Key Contact of the Year 2015 For commitment to advocacy on behalf of The Society of Thoracic Surgeons Yuma Regional Medical Center 2014 – 2019

Yuma, Arizona

September 2014 – January 2018, worked on a part time, limited basis to relieve a Cardiothoracic Surgeon and assist in developing the Catheter Based (TAVR) heart valve program. Beginning in late February 2018 worked to develop a current Cardiac, Thoracic, and Vascular Surgery program at YRMC.

Resigned privileges in February 2019

Cardima 2011 2013

California Based medical device

Developed device and study protocol for minimally Company invasive procedures to treat atrial fibrillation

During this time, I resided in North Carolina and did not practice medicine in Arizona Desert Cardiothoracic Surgeons July 1995 to May 2013* Phoenix, AZ Cardiothoracic and Vascular Surgery

*I was associated with this group and President, as noted below, but I did not practice medicine in Arizona with the group between July 9, 2011, and May 30, 2013 Adult Cardiac, Thoracic and Peripheral Vascular Surgery 450 550 Cases each year 200 Cardiac procedures; 250 350 Thoracic and Vascular procedures 400+ Root/arch replacements Stentless valves, valve repair, minimally invasive techniques, TMR 1% Mortality Rate 1% Infection Rate

1% Re exploration for bleeding rate

Atrial Arrhythmia Surgery

80+ Thoracoscopic Maze Procedures yearly

50+ Open Concomitant or Primary Full Maze Procedures yearly Endovascular Procedures – Full Privileges at 4 Hospitals Most ELGs for aneurysm in Arizona in 2009 200+ angiograms yearly

100+ interventions yearly

All aspects of minimally invasive intervention including PTA, Peripheral and Carotid Stent placement, Embolization, Lytic therapy, Vena Cava filter placement, Re canalization of Total Occlusion, Treatment of DVT via mechanical and chemical thrombolysis

Consulting in development of new surgical treatments of Atrial Fibrillation Advocacy on behalf of The Society of Thoracic Surgeons

Society of Thoracic Surgeons Key Contact 2012 to present Support key policy and legislative initiatives – regular travel to Washington DC to meet with legislators and staff

President of Desert Cardiothoracic Surgeons 2003 – 2013 Multi surgeon specialty group in multiple Hospitals More than 1,000 annual procedures

President of Medical Staff of Banner Heart Hospital 2001 – 2003 Largest Heart Hospital in Arizona

Medical Staff of more than 300 800+ operations annually Chairman of Banner Cardiovascular Committee 1999 – 2001 Surgical and Medical oversight of two 300 bed hospitals Member of multiple hospital committees on Cardiac, Vascular and Endovascular issues Cardiothoracic Residency 7/93 – 6/95

Congenital and Adult Cardiac, Thoracic and Peripheral Vascular Surgery – 750 cases General Surgery Residency 7/87 – 6/92

All aspects of General Surgery – 2300 cases

IBM Corporation 1980 – 1983

Large Computer Systems Consultant

Marketing and Technical Support to Large Corporations HONORS AND AWARDS:

PHI ETA SIGMA Honor Society

Howard Holderness Research Fellow 1985 1987 Third Place Medical Student Research Day 1986 Medical Student Research Society President 1986 First Place Resident and Fellows Research Day 1993 STS Key Contact of the Year 2015

RESEARCH EXPERIENCE:

Major studies:

Principal Investigator Cook Zenith Thoracic Endograft One of 40 study sites for the Cook Thoracic Endograft Principal Investigator National Marfan Foundation Aortic Valve Operative Outcomes in Marfan Patients Study 22 United States study sites

Evaluation of Aortic Root strategies in treating the Aortic Valve National Marfan Foundation Designated Site for Arizona Designated as the Arizona Site for treatment of the Marfan Syndrome as selected by the National Marfan Foundation

Principal Investigator Resolve 2 AF Trial

FDA Approved Study to investigate the clinical validity of minimally invasive surgery to treat Atrial Fibrillation

Principal Investigator Moxie Pharmaceutical Trial

FDA Approved study to evaluate the effects of a novel anti inflammatory medication on the biologic behavior of atherosclerotic plaque harvested from extremity arteries by directional Atherectomy Principal Investigator Cardima Asian Trial for the Treatment of Atrial Fibrillation International trial to evaluate efficacy of Cardima minimally invasive therapies for Atrial Fibrillation PRESENTATIONS: ORAL PRESENTATIONS (at National Meetings):

1. Hudspeth DA, Thorne MT, Conroy R, Pennell TC. Management of epiphrenic esophageal diverticula. A fifteen year experience. Annual Meeting of the Southeastern Surgical Congress, Atlanta, Georgia, May 31 June 3, 1992.

2. Hudspeth DA, Hansen KJ, Reavis SW, Starr SM, Appel RG, Dean RH. Renal duplex sonography after treatment of renovascular disease.

Seventeenth Annual Meeting of the

Southern Association for Vascular Surgery, Fort Lauderdale, Florida, January 28 31, 1993. 3. Nakanishi K, Zhoa Z Q, Vinten Johansen J, McGee DS, Hudspeth DA, Lewis JC, Hammon, Jr. JW. The effects of blood cardioplegia on the coronary vascular endothelium. 1993 FASEB Meeting. New Orleans, LA, March 28 April 1, 1993.

4. Hudspeth DA, Nakanishi K, Vinten Johansen J, Zhao Z Q, McGee DS, Hammon, Jr. JW. Enhancement of blood cardioplegia with adenosine avoids postischemic dysfunction in severely injured hearts. American College of Surgeons, 79th Annual Clinical Congress, San Francisco, CA, October 10 15, 1993.

5. Nakanishi K, Zhao Z Q, Vinten Johansen J, Hudspeth DA, Hammon JW. Blood cardioplegia enhanced with an organic nitric oxide donor reverses postischemic ventricular dysfunction and coronary endothelial damage. American College of Surgeons, 79th Annual Clinical Congress, San Francisco, CA, October 10 15, 1993. 6. Zhao Z Q, McGee DS, Nakanishi K, Hudspeth DA, Williams MW, Vinten Johansen J, Van Wylen DGL. Acadesine reduces infarct size without augmenting interstitial adenosine levels during coronary occlusion in the rabbit. American Heart Association, 66th Scientific Sessions, Atlanta, GA, November 8 11, 1993.

7. Hudspeth DA, Williams MW, Zhao Z Q, Sato H, Nakanishi K, Mcgee DS, Vinten Johansen J, Hammon, Jr. JW, Van Wylen DGL. Pretreatment pentostatin augments interstitial adenosine and prevents postischemic dysfunction in canine hearts protected with blood cardioplegia. 30th Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, January 31 February 2, 1994.

8. Hudspeth DA, Thorne MT, Meredith JW. Operative management of duodenal injuries. American College of Surgeons, 78th Annual Clinical Congress, New Orleans, LA, October 10 16, 1992. 9. Hudspeth DA Jost CM, Maxwell MC. Thoracoscopic Maze Procedure is Effective Treatment for Atrial

Fibrillation. American Heart Association Clinical Congress Dallas, TX, November 16, 2005 10. Hudspeth DA, Kaplan A, Maxwell MC. Thoracoscopic Left Atrial Ablation Provides Mid Term Freedom

From Intermittent Atrial Fibrillation. AATS Meeting Washington, DC May 15, 2007 11. Hudspeth DA, STS University Course #7 – Atrial Fibrillation Surgical Ablation: Concomitant and StandAlone; Why, How and Results. Society of Thoracic Surgeons 44th Annual Meeting, Ft. Lauderdale, FL January 2008

POSTER PRESENTATIONS (MEETINGS):

1. Beckman WC, Hudspeth DA, Golding TS, Hubbert L, Korach KS. Synchrony of bimodal estrogen receptor binding and DNA synthesis in athymic mouse uterus and human breast xenografts. 69th Annual Meeting of the Endocrine Society, Indianapolis, IN, 1987. 2. Hudspeth DA, Thorne MT, Meredith JW. A prospective evaluation of a simplified endoscopic technique for nasoenteric feeding tube placement. Society of Critical Care Medicine, 21st Educational and Scientific Symposium, San Antonio, TX, May 25 29, 1992. 3. Hudspeth DA, Williams MW, Zhao Z Q, Sato H, Nakanishi K, Mcgee DS, Vinten Johansen J, Hammon, Jr. JW, Van Wylen DGL. Pretreatment pentostatin augments interstitial adenosine and prevents postcardioplegia

injury in damaged hearts. International symposium on Myocardial Protection from Surgical Ischemic Reperfusion Injury, Asheville, NC, September 25 29, 1994. IN HOUSE PRESENTATIONS:

Poster Presentations:

Division of Surgical Sciences, Residents’ and Fellows’ Research Day 1. Hudspeth DA, Thorne MT, Meredith JW. A Prospective evaluation of a simplified endoscopic technique for nasoenteric feeding tube placement. November 17, 1993. 2. Hudspeth DA, Nakanishi K, Vinten Johansen J, Zhao Z Q, McGee DS, Hammon, Jr. JW. Enhancement of blood cardioplegia with adenosine avoids postischemic dysfunction in severely injured hearts. November 17, 1993.

3. Nakanishi K, Zhao Z Q, Vinten Johansen J, Hudspeth DA, Hammon JW. Blood cardioplegia enhanced with an organic nitric oxide donor reverses postischemic ventricular dysfunction and coronary endothelial damage. November 17, 1993. 4. Zhao Z Q, McGee DS, Nakanishi K, Hudspeth DA, Williams MW, Vinten Johansen J, Van Wylen DGL. Acadesine reduces infarct size without augmenting interstitial adenosine levels during coronary occlusion in the rabbit. November 17, 1993. 5. Hudspeth DA, Williams MW, Zhao Z Q, Sato H, Nakanishi K, Mcgee DS, Vinten Johansen J, Hammon, Jr. JW, Van Wylen DGL. Pretreatment pentostatin augments interstitial adenosine and prevents postcardioplegia injury in damaged hearts. September 22, 1994. SELECTED ORAL PRESENTATIONS (IN HOUSE):

• Adenocarcinoma of the Gastroesophageal Junction

• Aortic valve replacement with stentless porcine aortic bioprosthesis in the canine model The extended transeptal approach to mitral valve procedure using the canine model Adenosine Metabolism in Myocardial Protection

• Thoracic Trauma

• PET Scanning for Thoracic Neoplasms Thymoma

• Surgical Decision Making in Myocardial Revascularization Esophageal Diverticula

• Alternative Imaging Studies in Gastrointestinal Bleeding Aortic Dissection Thoracoabdominal

• Aneurysms Staging Lung Cancer Mediastinal Masses

• Surgical Management of Endocarditis Atrial Septal Defects

• Ventricular and associated Cardiac Defects Traumatic Cardiac Injury

• Postischemic Ventricular Septal Defect Congenital Pulmonary Malformations Aneurysms

• Endovascular repair of Thoracic Aneurysms Surgical Management of Atrial Fibrillation • Community education on management of Atrial Fibrillation BIBLIOGRAPHY:

Journal Articles

1. Beckman WC, Hudspeth DA, Golding TS, Hubbert L, Korach KS. Bimodal nuclear estrogen receptor binding: Synchrony in athymic mouse uterus and human breast xenografts. Endocrinology 124(6): 2651 8, 1989.

2. Hudspeth DA, Nakanishi K, Vinten Johansen J, Zhao Z Q, McGee DS, Hammon, Jr. JW. Enhancement of blood cardioplegia with adenosine avoids postischemic dysfunction in severely injured hearts. Surgical Forum 44: 252 254, 1993.

3. Nakanishi K, Zhao Z Q, Vinten Johansen J, Hudspeth DA, Hammon JW. Blood cardioplegia enhanced with an organic nitric oxide donor reverses postischemic ventricular dysfunction and coronary endothelial damage. Surgical Forum 44: 245 247, 1993. 4. Nakanishi K, Zhao Z Q, Vinten Johansen J, Hudspeth DA, Mcgee DS, Hammon JW. Blood cardioplegia enhanced with the organic nitric oxide donor SPM 5185 counteracts postischemic endothelial and ventricular dysfunction. J Thor Cardiovasc Surg 109(6): 1146 54, 1995. 5. Zhao Z Q, Williams MW, Sato H, Hudspeth DA, McGee DS, Vinten Johansen J, Van Wylen DGL. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism. Cardiovasc Res 29(4): 495 505, 1995.

6. Hudspeth DA, Williams MW, Zhao Z Q, Sato H, Nakanishi K, Mcgee DS, Vinten Johansen J, Hammon, Jr. JW, Van Wylen DGL. Pentostatin augmented interstitial adenosine prevents cardioplegia injury in damaged hearts. Ann Thorac Surg 58(3): 719 27, 1994.

7. Hudspeth DA, Nakanishi K, Vinten Johansen J, Zhao Z Q, McGee DS, Hammon, Jr. JW. Adenosine in Blood Cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 58(6): 1637 44, 1995.

8. Hudspeth DA, Thorne MT, Meredith JW. A simple endoscopic technique for nasoenteric feeding tube placement. JACS 180(2): 229 30, 1995.

9. Hudspeth DA. Invited comment on nasoenteric feeding techniques. JACS 181 (1): 109 10, 1995. 10. Hudspeth DA, Thorne MT, Conroy R, Pennell TC. Management of epiphrenic esophageal diverticula. A fifteen year experience. The American Surgeon 59: 40 49, 1993. 11. Hudspeth DA, Hansen KJ, Reavis SW, Starr SM, Appel RG, Dean RH. Renal duplex sonography after treatment of renovascular disease. J Vasc Surg 18:381 390, 1993. 12. Hudspeth DA, Kaplan A, Maxwell MC. Thoracoscopic Left Atrial Ablation Provides Mid Term Freedom From Intermittent Atrial Fibrillation. JTCVS, in press. Articles Submitted or in Preparation

1. Hudspeth DA, Thorne MT, Meredith JW. Operative management of duodenal injuries. 2. Hudspeth DA, Hudspeth AS. Anomalous right coronary artery and aortopulmonary window. 3. Hudspeth DA, Hudspeth AS. Safer carotid endarterectomy with operations involving cardiopulmonary bypass.

4. Hudspeth DA, Hudspeth AS. Massive hemoptysis due to ruptured bronchial artery aneurysm. Abstracts

1. Golding TS, Gully J, Korach KS, Beckman WC, Hudspeth DA. Multiple Nuclear Estrogen Receptor Peaks: Salt Resistance and Appearance in Different Target Tissues. Proceedings of the 67th Meeting of the Endocrine Society, 1985 (abstract 1149). 2. Beckman WC, Hudspeth DA, Golding TS, Hubbert L, Korach KS. Synchrony of Bimodal Estrogen Receptor Binding and DNA Synthesis in Athymic Mouse Uterus and Human Breast Tumor Xenografts. Proceedings of the 69th Meeting of the Endocrine Society, 1987 (abstract 200). 3. Nakanishi K, Zhao Z Q, Vinten Johansen J, McGee DS, Hudspeth DA, Lewis JC, Hammon Jr., JW. The effects of blood cardioplegia on the coronary vascular endothelium. FASEB J 7(3): A122, 1993.

4. Zhao Z Q, Williams MW, Sato H, Hudspeth DA, McGee DS, Vinten Johansen J, Van Wylen DGL. Acadesine reduces infarct size without augmenting interstitial adenosine levels during coronary occlusion in the rabbit. Circulation 88(Part 2): I 432, 1993. 5. Hudspeth DA, Thorne MT, Meredith JW. A prospective evaluation of a simple endoscopic technique for nasoenteric feeding tube placement. Crit Care Med,

Contact this candidate